Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (661-670 of 779) with videos related to

Pageof 78
Sort By:
Journal of Cancer|July 11, 2019
Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese PopulationYawen Sun, Tao Zhang, Wenjie Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2018
A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung CancerJuheon Lee, Bailiang Li, Yi Cui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 17, 2013
Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: a prospective, multicenter phase II trailXue Meng, Jianhua Wang, Xindong Sun, et al.
BMC Cancer|January 3, 2024
The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapyXin Xu, Wei Zhao, Cuicui Liu, et al.
Nature Immunology|June 17, 2020
Redox homeostasis maintained by GPX4 facilitates STING activationMutian Jia, Danhui Qin, Chunyuan Zhao, et al.
Cancer Letters|October 2, 2025
Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathwayWenxiao Jia, Lin Ma, Menglin Bai, et al.
Clinical Lung Cancer|July 10, 2013
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancerXiaolin Li, Huaqi Zhang, Ligang Xing, et al.
Frontiers in Oncology|November 16, 2020
Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung CancerMeng Ni, Wenju Liu, Aijun Jiang, et al.
The International Journal of Biochemistry & Cell Biology|July 11, 2021
JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1Qun Wang, Jing Wu, Hua Wei, et al.
Cancer Science|November 24, 2018
Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancerKai Hu, Ning Kang, Yang Liu, et al.
Pageof 78

Showing results (661-670 of 779) with videos related to

Sort By:
Pageof 78
Journal of Cancer|July 11, 2019
Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese PopulationYawen Sun, Tao Zhang, Wenjie Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2018
A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung CancerJuheon Lee, Bailiang Li, Yi Cui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 17, 2013
Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: a prospective, multicenter phase II trailXue Meng, Jianhua Wang, Xindong Sun, et al.
BMC Cancer|January 3, 2024
The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapyXin Xu, Wei Zhao, Cuicui Liu, et al.
Nature Immunology|June 17, 2020
Redox homeostasis maintained by GPX4 facilitates STING activationMutian Jia, Danhui Qin, Chunyuan Zhao, et al.
Cancer Letters|October 2, 2025
Loss of ADAR1 in lung cancer activates anti-tumour immunity and suppresses tumour cell growth via the RIG-I/MDA5-MAVS pathwayWenxiao Jia, Lin Ma, Menglin Bai, et al.
Clinical Lung Cancer|July 10, 2013
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancerXiaolin Li, Huaqi Zhang, Ligang Xing, et al.
Frontiers in Oncology|November 16, 2020
Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung CancerMeng Ni, Wenju Liu, Aijun Jiang, et al.
The International Journal of Biochemistry & Cell Biology|July 11, 2021
JARID2 promotes stemness and cisplatin resistance in non-small cell lung cancer via upregulation of Notch1Qun Wang, Jing Wu, Hua Wei, et al.
Cancer Science|November 24, 2018
Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancerKai Hu, Ning Kang, Yang Liu, et al.
Pageof 78